RGRX
Price:
$0.0007
Market Cap:
$1.05K
RegeneRx Biopharmaceuticals, Inc. is a biotechnology firm dedicated to the advancement of therapeutic peptides, with a primary emphasis on thymosin beta 4, engineered for the protection, repair, and regeneration of tissues and organs. The company's development pipeline includes RGN-259, a preservative-free ophthalmic solution designed to restore corneal tissues following injury, disease, or other pathologies; RGN-352, an injectable formulation under investigation for its potential in treating cardiovascular ailments, central and peripheral nervous system disorders, and various other medical conditions; and RGN-137, a topical gel aimed at accelerating the healing of skin wounds and minimizing...[Read more]
Industry
Biotechnology
IPO Date
2003-10-07
Stock Exchange
OTC
Ticker
RGRX
According to RegeneRx Biopharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 60.86%. This represents a change of 364.85% compared to the average of 13.09% of the last 4 quarters.
The mean historical ROE of RegeneRx Biopharmaceuticals, Inc. over the last ten years is 59.56%. The current 60.86% ROE has changed 2.19% with respect to the historical average. Over the past ten years (40 quarters), RGRX's ROE was at its highest in in the March 2014 quarter at 98.25%. The ROE was at its lowest in in the December 2017 quarter at -34.43%.
Average
59.56%
Median
56.96%
Minimum
-6.96%
Maximum
160.90%
Discovering the peaks and valleys of RegeneRx Biopharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 288.80%
Maximum Annual ROE = 160.90%
Minimum Annual Increase = -1395.18%
Minimum Annual ROE = -6.96%
| Year | ROE | Change |
|---|---|---|
| 2022 | 50.12% | -30.06% |
| 2021 | 71.66% | 32.88% |
| 2020 | 53.93% | -10.11% |
| 2019 | 60.00% | -33.44% |
| 2018 | 90.14% | -1395.18% |
| 2017 | -6.96% | 84.28% |
| 2016 | -3.78% | -104.83% |
| 2015 | 78.16% | -51.42% |
| 2014 | 160.90% | 288.80% |
| 2013 | 41.38% | -50.00% |
The current ROE of RegeneRx Biopharmaceuticals, Inc. (RGRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
58.57%
5-year avg
65.17%
10-year avg
59.56%
RegeneRx Biopharmaceuticals, Inc.’s ROE is less than BioSyntech, Inc. (517.27%), less than Nascent Biotech, Inc. (268.93%), less than Hemagen Diagnostics, Inc. (29.06%), less than ChitogenX Inc. (19.40%), less than Qrons Inc. (5.80%), greater than Quantum Medical Transport, Inc. (-1.05%), greater than ViaDerma, Inc. (-0.48%), less than 4Front Ventures Corp. (788.56%), less than Actavia Life Sciences, Inc. (243.82%), less than Forza Innovations Inc. (160.25%),
| Company | ROE | Market cap |
|---|---|---|
| 517.27% | $229.03K | |
| 268.93% | $34.44K | |
| 29.06% | $3.10K | |
| 19.40% | $627.63K | |
| 5.80% | $199.80K | |
| -1.05% | $23.98K | |
| -0.48% | $246.74K | |
| 788.56% | $12.46K | |
| 243.82% | $385.91K | |
| 160.25% | $252.18K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RegeneRx Biopharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like RegeneRx Biopharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is RegeneRx Biopharmaceuticals, Inc.'s ROE?
How is the ROE calculated for RegeneRx Biopharmaceuticals, Inc. (RGRX)?
What is the highest ROE for RegeneRx Biopharmaceuticals, Inc. (RGRX)?
What is the 3-year average ROE for RegeneRx Biopharmaceuticals, Inc. (RGRX)?
What is the 5-year average ROE for RegeneRx Biopharmaceuticals, Inc. (RGRX)?
How does the current ROE for RegeneRx Biopharmaceuticals, Inc. (RGRX) compare to its historical average?